API Nanotronics Corp.·4

Jul 3, 12:37 PM ET

API Nanotronics Corp. 4

4 · API Nanotronics Corp. · Filed Jul 3, 2007

Insider Transaction Report

Form 4
Period: 2007-07-02
MOSKOVITS MARTIN
Chief Technology Officer
Transactions
  • Award

    Option (Right to Buy)

    2007-07-02+700,000700,000 total
    Exercise: $1.34From: 2007-06-29Exp: 2011-06-29Common Stock (700,000 underlying)
  • Award

    Option (Right to Buy)

    2007-07-02+300,000300,000 total
    Exercise: $1.34From: 2007-06-29Exp: 2011-06-29Common Stock (300,000 underlying)
  • Disposition to Issuer

    Option (Right to Buy)

    2007-07-02700,0000 total
    Exercise: $1.60From: 2007-06-29Exp: 2011-06-29Common Stock (700,000 underlying)
  • Disposition to Issuer

    Option (Right to Buy)

    2007-07-02300,0000 total
    Exercise: $2.06From: 2007-06-29Exp: 2011-06-29Common Stock (300,000 underlying)
Footnotes (4)
  • [F1]The options vest as follows: 140,000 on June 29, 2007; 140,000 on the date issuer has a facility that can be used for research and development purposes or for the production of nano-related products or such earlier date that the Board of Directors in its discretion decides that this vesting condition has been waived or cannnot be satisfied as a result of decisions made by the Board of Directors; 140,000 on June 29, 2008; 140,000 on June 29, 2010; and 140,000 upon receipt by issuer of $5,000,000 of commitments in total grants or funding from third parties related to the research and/or development of nanotechnology or related products
  • [F2]The options vest as follows: 60,000 on June 29, 2007; 60,000 on the date issuer has a facility that can be used for research and development purposes or for the production of nano-related products or such earlier date that the Board of Directors in its discretion decides that this vesting condition has been waived or cannnot be satisfied as a result of decisions made by the Board of Directors; 60,000 on June 29, 2008; 60,000 on June 29, 2010; and 60,000 upon receipt by issuer of $5,000,000 of commitments in total grants or funding from third parties related to the research and/or development of nanotechnology or related products
  • [F3]The reporting person agreed to cancellation of an option granted to him on November 6, 2006, in exchange for a new option having a lower exercise price.
  • [F4]The reporting person agreed to cancellation of an option granted to him on November 28, 2006, in exchange for a new option having a lower exercise price.

Documents

1 file
  • 4
    rrd164336.xmlPrimary

    REPRICING OF OPTION